Andrew Hirsch
2018 - Agios Pharmaceuticals
In 2018, Andrew Hirsch earned a total compensation of $3.1M as Chief Financial Officer and Head of Corporate Development at Agios Pharmaceuticals, a 35% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $265,123 |
|---|---|
| Option Awards | $1,746,517 |
| Salary | $471,329 |
| Stock Awards | $641,025 |
| Other | $12,864 |
| Total | $3,136,858 |
Hirsch received $1.7M in option awards, accounting for 56% of the total pay in 2018.
Hirsch also received $265.1K in non-equity incentive plan, $471.3K in salary, $641K in stock awards and $12.9K in other compensation.
Rankings
In 2018, Andrew Hirsch's compensation ranked 3,680th out of 14,244 executives tracked by ExecPay. In other words, Hirsch earned more than 74.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,680 out of 14,244 | 74th |
Division Manufacturing | 1,364 out of 5,759 | 76th |
Major group Chemicals And Allied Products | 482 out of 2,122 | 77th |
Industry group Drugs | 401 out of 1,811 | 78th |
Industry Pharmaceutical Preparations | 309 out of 1,385 | 78th |
Pay ratio
| Andrew Hirsch's Pay | $3,136,858 |
|---|---|
| Median Employee's Pay | $345,181 |
| Pay Ratio | 9to 1 |
In 2018, the annual total compensation of Andrew Hirsch was $3,136,858.
The annual total compensation of the median employee at Agios Pharmaceuticals was $345,181.
The ratio of Andrew Hirsch's pay to the pay of median employee was therefore 9 to one.
Source: SEC filing on April 18, 2019.
Hirsch's colleagues
We found four more compensation records of executives who worked with Andrew Hirsch at Agios Pharmaceuticals in 2018.